Skip to main content
Download PDF

Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers

Respiratory Research volume 20, Article number: 128 (2019) Cite this article

Abstract

Background

Elastin breakdown and the resultant loss of lung elastic recoil is a hallmark of pulmonary emphysema in susceptible individuals as a consequence of tobacco smoke exposure. Systemic alterations to the synthesis and degradation of elastin may be important to our understanding of disease phenotypes in chronic obstructive pulmonary disease. We investigated the association of skin elasticity with pulmonary emphysema, obstructive lung disease, and blood biomarkers of inflammation and tissue protease activity in tobacco-exposed individuals.

Methods

Two hundred and thirty-six Caucasian individuals were recruited into a sub-study of the University of Pittsburgh Specialized Center for Clinically Orientated Research in chronic obstructive pulmonary disease, a prospective cohort study of current and former smokers. The skin viscoelastic modulus (VE), a determinant of skin elasticity, was recorded from the volar forearm and facial wrinkling severity was determined using the Daniell scoring system.

Results

In a multiple regression analysis, reduced VE was significantly associated with cross-sectional measurement of airflow obstruction (FEV1/FVC) and emphysema quantified from computed tomography (CT) images, β = 0.26, p = 0.001 and β = 0.24, p = 0.001 respectively. In emphysema-susceptible individuals, elasticity-determined skin age was increased (median 4.6 years) compared to the chronological age of subjects without emphysema. Plasma biomarkers of inflammation (TNFR1, TNFR2, CRP, PTX3, and SAA) and matrix metalloproteinase activity (MMP1, TIMP1, TIMP2, and TIMP4) were inversely associated with skin elasticity.

Conclusions

We report that an objective non-invasive determinant of skin elasticity is independently associated with measures of lung function, pulmonary emphysema, and biomarkers of inflammation and tissue proteolysis in tobacco-exposed individuals. Loss of skin elasticity is a novel observation that may link the common pathological processes that drive tissue elastolysis in the extracellular matrix of the skin and lung in emphysema-susceptible individuals.

Background

Cigarette smoking is the most important risk factor for the development of chronic obstructive pulmonary disease (COPD) in the developed world and is a major cause of premature morbidity and mortality [1]. Comorbidities associated with COPD, such as osteoporosis, cardiovascular disease, and skeletal muscle atrophy, appear to correlate with the parenchymal emphysema dominant pattern of lung disease, and with a prevalence disproportionate to what would be expected in a similar tobacco-exposed population [2,3,4,5]. Systems biology approaches, which incorporate computational modelling of specific genetic, molecular, and cellular processes, have provided new perspectives on the mechanisms that drive the varying manifestations of pulmonary and multisystem disease in COPD [6, 7]. Identification of important pathogenic mechanisms that drive pulmonary and comorbid illness in COPD, including systemic inflammation, oxidative stress, and protease imbalance, have helped inform novel therapeutic advances in COPD [8, 9]. However an individual’s susceptibility to the complex pathogenic mechanisms underlying the development of airflow obstruction, emphysema, and associated systemic comorbid findings in smokers remains incompletely understood [10, 11].

Cutaneous manifestations of COPD affecting skin texture, thickness, and connective tissue integrity have been historically described [12]. More recent reports indicate that an independent association exists between facial wrinkling and airflow obstruction, which suggests that the lung and skin share common susceptibility to the deleterious effects of tobacco smoke exposure [13]. Facial wrinkle formation results from immobilization of transient wrinkles due to loss of skin elasticity and is influenced by aging, ultraviolet light exposure, and smoking [14, 15]. Furthermore, tobacco smoke exposure is known to be an independent risk factor for premature facial wrinkling [16,17,18]. In smokers with COPD, elastin degradation in the skin is associated with emphysema severity and carotid pulse wave velocity, indicating that systemic elastin breakdown may be increased in susceptible individuals and not confined to the lung alone [19]. Skin elasticity, a key biomechanical property of skin, decreases significantly with age, is quantifiable, and changes in disease states caused by genetic disruption of elastic fibers, such as cutis laxa [20]. Taken together, alterations in skin elasticity may represent a novel non-invasive measure of the systemic effects that alter the extracellular matrix (ECM) in response to tobacco smoke in COPD.

We evaluated skin elasticity and facial wrinkling in a prospective cohort of well characterized current and former smokers. We hypothesized that skin elasticity would correlate with the severity of pulmonary disease in susceptible tobacco-exposed individuals and be associated with systemic markers of inflammation and tissue protease imbalance.

Methods

Study population

Study participants (n = 236) were recruited prospectively into a sub-study from the University of Pittsburgh Specialized Center of Clinically Orientated Research (SCCOR) cohort, which includes current and former smokers aged > 40, with a minimum 10 pack-year tobacco exposure residing around southwestern Pennsylvania [21]. Participants completed demographic and medical history questionnaires including self-reported average weekly sunlight exposure. All data acquisition procedures were performed under a University of Pittsburgh Institutional Review Board-approved protocol with written informed consent obtained from all participants.

Skin elasticity measurement

Skin elasticity measurements were performed on the volar forearm of each subject using the Dermalab® (Cortex Technology, Denmark) skin elasticity unit as previously described [20, 22] (see Additional file 1: Figure S1). The volar forearm was chosen to reduce the confounding influence of photoaging as a consequence of ultraviolet light exposure. In brief, incremental negative pressure was applied using a 10 mm diameter suction cup secured midway along the volar forearm using a double-sided adhesive tape until the section of skin was raised 1.5 mm (Δx). Measured variables include the pressure difference required to lift the skin (ΔP), and the time the skin takes to return to its original position upon release of the vacuum (retraction time, RT). The mean of ten values per subject, taken from five locations on each forearm, was used for analysis. Young’s elastic modulus (E) was calculated by the DermaLab® software by solving the following equation: Δx = Ψ * ΔP * r4 / (E * s3), where Δx and ΔP are as described above, Ψ is an instrument constant, r is the radius of the skin patch displaced (0.005 m), and s is the estimated thickness of the skin (1 mm). The viscoelastic modulus (VE) was computed by the following formula: VE = E / RTn, where RTn is a normalized RT value obtained by dividing the measured RT value with average control RT of 260 ms.

Facial wrinkling score

Photographs were taken of all subjects using the same camera, subject distance from the camera, and lighting conditions. The left and right temporal regions, forehead and peri-oral region were photographed to assess facial wrinkling. Facial wrinkling was determined from the left and right temporal (Crow’s foot) region using the Daniell scoring system, a validated scale from 1 to 6 (1-unwrinkled; 2- < 6 wrinkles ≤3 cm in length; 3-wrinkles > 3 cm but < 5 cm; 4-wrinkles ≥5 cm; 5-wrinkles > 5 cm, over cheeks and forehead; 6-profound wrinkling) [23] (Fig. 1). Two independent observers, blinded to the subjects’ clinical information, rated left and right temporal wrinkling and reported a mean value. The average facial wrinkling score (FWS) of the two observers was used for analysis. Severe wrinkling was defined as a Daniell score ≥ 4 as previously described [13].

Fig. 1
figure 1

Measurement of facial wrinkling. Daniell system for scoring the appearance of facial wrinkles in the crow’s-foot area: 1) Essentially unwrinkled. 2) Between 2 and 6 wrinkles ≤3 cm in length. 3) Several prominent wrinkles 3-4 cm in length. 4) Wrinkles ≥5 cm in length, may extend onto cheek area. 5) Prominent wrinkles extending from crow’s-foot area over cheeks and forehead. 6) Profound wrinkling over most of the face

Full size image

Clinical phenotype

Post-bronchodilator spirometry, lung volumes by body plethysmography, and single breath diffusing capacity of the lung for carbon monoxide (DLCO) were performed in each study participant according to American Thoracic Society standards [24] using standard reference eqs. [24,25,26]. Emphysema was quantified from chest computed tomography (CT) images acquired on multi-detector scanners with subjects holding their breath at end-inspiration. After segmenting the lung from the CT images, the Hounsfield unit (HU) value designating the lower 15th percentile of the HU value histogram (Perc15) and the percentage of lung voxels below − 950 HU (%LAA) were computed to quantify emphysema. A single radiologist, blinded to subject identities and other characteristics, visually assessed emphysema severity using a previously validated, 6-point semi-quantitative scoring system (0 = none, 1 = trace/minimal, 2 = mild, 3 = moderate, 4 = severe, 5 = very severe, corresponding to 0, < 10%, 10–25%, 26–50%, 51–75, and > 75% visual emphysema) [27]. For non-continuous analysis, COPD was defined using FEV1/FVC less than 70%. and subjects were categorized as having no emphysema based on a visual emphysema score of zero.

Biomarker measurement

Plasma and serum were drawn from participants using standardized phlebotomy procedures, then separated immediately by centrifugation and frozen for later analysis. A bead-based immunoassay was performed for quantification of tumor necrosis factor α (TNFα), TNF receptor 1 (TNF-R1), and TNF-R2 (Invitrogen). Matrix metalloproteases (MMP) and tissue inhibitors of metalloproteases (TIMP), including MMP1, MMP7, TIMP1, TIMP2, and TIMP4, were assayed using Performance Assay Luminex kits (R&D Systems). C reactive protein (CRP) and serum amyloid A (SAA) were measured using V-Plex assay kit (MSD). Pentraxin 3 (PTX3) was measured using DuoSet enzyme-linked immunoassays (R&D Systems).

Statistical analysis

Bland-Altman analysis was performed to determine agreement between the two independent observers scoring facial wrinkling severity. Bivariate and multiple regression models were used to determine relationships between facial wrinkling score (FWS) and skin viscoelastic modulus (VE) with spirometric measures of airflow obstruction, CT-assessed emphysema, and biomarkers of matrix-metalloprotease activity. Adjustment for covariates included age, gender, self-reported sunlight exposure, current smoking status, and self-reported pack-year smoking history. Analyses were carried out with Stata v13.0 (StataCorp, Texas), and graphs were generated using Prism v6 (GraphPad Software, Inc., California). Relationships were reported using the standardized coefficient (β) and statistical significance was determined as a two-tailed P-value < 0.05.

Results

Subject characteristics

All subjects (n = 236) were Caucasian with a mean age of 70.4 ± 5.9 years, they were all current or prior smokers and gender was equally balanced with 123 (52.1%) males (Table 1). One hundred and thirteen (47.9%) subjects had COPD based on spirometry (FEV1/FVC < 0.70) with severity being nearly equally distributed between GOLD Stage I to IV COPD. Emphysema was detected by visual inspection of CT images in 130 (55.1%) subjects.

Table 1 Subject Characteristics
Full size table

Skin elasticity correlates with Daniell facial wrinkling score

Bland-Altman analysis of facial wrinkling scores found excellent agreement between the two observers with a mean difference of − 0.063 (95% limits of agreement: − 1.25 to 1.12), intraclass correlation coefficient (ICC) of average for one-way random effects: 0.94 (95% confidence interval 0.93–0.96). There was a significant inverse correlation between VE and the facial wrinkling score, indicative of their biological association (β = − 0.29, P < 0.001).

Bivariate analysis of skin elasticity and baseline demographics

As anticipated, VE was inversely correlated with age (β = − 0.49, P < 0.0001). Male gender (β = − 0.16, P = 0.017) and longer pack-year smoking history (β = − 0.20, P = 0.002) were also associated with lower VE, while increased BMI was associated with a higher VE (β = 0.46, P < 0.0001) (Table 2). The association between self-reported weekly sun exposure and VE was not significant (P = 0.18). Bivariate analysis of facial wrinkling revealed a significant association with age (β = 0.25, P < 0.001) and BMI (β = − 0.15, P = 0.025), but not with self-reported sun exposure (P = 0.72).

Table 2 The skin viscoelastic modulus correlates with facial wrinkling, age, sex, body mass index, and pack years in current or former smokers
Full size table

Skin elasticity correlates with cross-sectional measures of lung function

Bivariate and multiple regression analysis of VE following adjustment for covariates (age, gender, sunlight exposure, current smoking and pack-year smoking history) demonstrated a significant relationship with measures of spirometry, gas transfer, air trapping, and quantitative emphysema (Perc15, %LAA) (Table 3). FEV1/FVC was strongly associated with lower VE measurements, in contrast FEV1 did not correlate with skin elasticity in the bivariate analysis; however, a significant association did emerge after correction for covariates. There was no association in the bivariate or multiple regression analyses between FWS and cross-sectional FEV1, FEV1/FVC, RV/TLC, or quantitative emphysema severity. Notably, facial wrinkling was significantly associated with DLCO (β = − 0.13, P = 0.04), the physiologic correlate most linked with emphysema severity, and remained significant in the adjusted analysis (Table 3).

Table 3 The skin viscoelastic modulus is an independent predictor of pulmonary emphysema and airflow obstruction
Full size table

Loss of skin elasticity is associated with an increased likelihood of pulmonary emphysema

Quartile analysis revealed a significant association between decreased VE and lower FEV1/FVC (P-trend = 0.001), DLCO %predicted (P-trend < 0.0001), and Perc15 (P-trend = 0.025), while RV/TLC (P-trend < 0.0001) and %LAA (P-trend = 0.007) were increased (Fig. 2).

Fig. 2
figure 2

Loss of skin elasticity is associated with greater impairment in lung function and increased pulmonary emphysema. Skin elasticity was associated with pulmonary emphysema determined by %LAA and Hist15. Skin elasticity was not associated with impairment in FEV1, however a significant association was observed between quartiles of skin elasticity and the severity of airflow obstruction, diffusion impairment, lung hyperinflation (RV/TLC) and pulmonary emphysema. Legend: FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity in 1 s; DLCO, diffusion capacity for carbon monoxide; LAA% = low attenuation areas, lung voxels with Hounsfield Unit (HU) values less than −950; Perc15, HU value at the 15th percentile of the HU value histogram of lung voxels

Full size image

In a logistic regression analysis following adjustment for covariates (age, gender, sun exposure, current smoking, and pack year smoking history), the lowest quartile of VE was associated with an increased likelihood of airflow obstruction, adjusted Odds Ratio (OR) 3.66, 95% C.I. 1.49 to 8.99, P = 0.005, and visually-assessed pulmonary emphysema, adjusted OR 2.89, 95% C.I. 1.12 to 7.47, P = 0.025 (Table 4).

Table 4 The lowest quartile of the skin viscoelastic modulus is independently associated with pulmonary emphysema
Full size table

Skin aging is accelerated in individuals with pulmonary emphysema

Loss of skin elasticity occurs as a natural consequence of aging and features of increased skin aging have been shown in patients with COPD [13, 28]. After stratification for the presence of pulmonary emphysema, we demonstrated significant differences in skin elasticity at a given chronological age using linear regression modelling, P = 0.0007 (Fig. 3a). Elasticity-determined skin age was predicted from the regression model using the linear intercepts of VE with chronological age from subjects with emphysema (Age = (VE-9.433)/− 0.09957) and without emphysema (Age = (VE-9.344)/− 0.09171) (Fig. 3b). Individuals susceptible to emphysema had lower skin elasticity at a given chronological age compared to current or former smokers without emphysema, consistent with an increased biological age of skin in the emphysema group (median difference 4.6 ± 1.3 years, P = 0.0007) (Fig. 3c). This finding remained significant after correction for multiple covariates (age, gender, sun exposure, current smoking, and pack year smoking history), subjects with emphysema had a mean reduction in VE of 0.46 (95% C.I. 0.26 to 0.66, P = 0.02), which equates to an approximate five-year increase in skin age. There was no interaction between age and emphysema in the adjusted analysis.

Fig. 3
figure 3

Biological skin aging is accelerated in individuals with pulmonary emphysema. a Elasticity-determined skin age was visualized using linear regression modelling of VE against age following stratification for the presence or absence of visually-assessed pulmonary emphysema. b Enlarged view of regression model that depicts the linear intercept of VE (value 3.5) with ‘Emphysema’ (green arrow) and ‘No Emphysema’ (purple arrow), the distance between arrows highlights the difference in years between the two groups (Δ). c Subjects with visually-assessed pulmonary emphysema had lower skin elasticity at a given chronological age compared to current or former smokers without emphysema, consistent with an increased biological age of skin in the emphysema group. Legend: VE; skin elasticity; Δ, delta/difference

Full size image

Plasma biomarkers of inflammation and protease activity are associated with skin elasticity

Lower skin elasticity values correlated with increasing plasma biomarkers of systemic inflammation, including the soluble TNFα receptors, TNFR1 and TNFR2, and the acute phase proteins, C-reactive protein (CRP), pentraxin-3 (PTX3), and serum amyloid A (SAA) (Table 5). No correlation was detected in plasma levels of the pro-inflammatory cytokines TNFα and IL-6 with either FWS or VE. Tissue inhibitors of metalloproteases, important regulators of the extracellular matrix, TIMP1, TIMP2, TIMP4, and matrix metalloproteinase 1 (MMP1) were higher in subjects with decreased skin elasticity. In a multiple regression analysis, biomarkers of inflammation, including TNFR2, CRP, and SAA, in addition to TIMP2 and TIMP4 remained significant after correction for current smoking status, pack year smoking history and degree of airflow obstruction (FEV1% predicted).

Table 5 The skin viscoelastic modulus is associated with blood biomarkers of inflammation and tissue metalloprotease activity
Full size table

Discussion

In this study we report that skin elasticity is strongly and independently associated with measures of airflow obstruction and radiographic pulmonary emphysema in a tobacco exposed population. Facial wrinkling did correlate strongly with skin elasticity, though unexpectedly it did not reach a statistically significant association with measures of airflow obstruction or extent of pulmonary emphysema. However, we found a previously unreported direct relationship between facial wrinkling and diffusion impairment, the physiologic correlate to emphysema. Furthermore, we observed that systemic biomarkers of inflammation and metalloprotease activity were inversely associated with skin elasticity, which remained significant after correction for smoking history and degree of airflow obstruction.

The findings of this study validate the concept of extracellular matrix susceptibility to tobacco smoke in the lung and the skin and corroborates the previous findings of increased skin elastosis in biopsy specimens from subjects with COPD compared to matched smokers [19]. Skin elasticity is an accessible and objective determinant of the biomechanical properties of the skin extracellular matrix that has been previously validated in several studies, though hitherto its utility in COPD was unknown [20, 29,30,31,32]. As an indirect measure of elastin degradation, skin elasticity reveals a stronger and more convincing association with emphysema than wrinkling and thus represents a viable alternative biomarker. Longitudinal follow up with interval VE measurement may help us determine the impact of continued smoking on skin elasticity and define the predictive value of VE on pulmonary disease progression.

An interesting finding, after stratification for the presence of emphysema, was evidence of more advanced biological aging in the skin of individuals with emphysema. This finding is supported by the well-studied pathological effects of tobacco smoke on non-sun exposed skin, that resemble accelerated aging, whereby dermal elastic fiber size and quantity are increased in smokers compared to age-matched controls without affecting dermal thickness [15, 33]. Notably, in this cross-sectional analysis, decreased skin elasticity was independently associated with emphysema susceptibility at any given chronological age, pointing to the persistent impact of noxious exposure at an earlier phase of the disease course.

Loss of tissue elastic recoil is a key physiological hallmark of pulmonary emphysema that ultimately leads to increased lung compliance, hyperinflation and functional impairment with advancement of disease [34]. Protease-antiprotease imbalance is a key underlying pathological mechanism in COPD and it is known that proteolytically cleaved elastin fibers are pro-inflammatory in the lung [35]. The role of degraded skin elastin contributing to a systemic pro-inflammatory state linked to progression of lung disease is unknown, though studies evaluating the utility of a byproduct of elastin cleavage, desmosine, as a biomarker of pulmonary disease have been inconclusive to date [36].

The proposed mechanism attributed to pathological changes observed in the skin of smokers relates the accumulation of elastin fragments, generated by increased protease activity surrounding the dermal vasculature or driven by toxic effects of tobacco smoke in this region, which may further stimulate elastin and ultrastructural microfibril deposition by dermal fibroblasts [37]. Skin elastin degradation is further increased in the sun-exposed skin of smokers which may belie a synergistic interaction between tobacco smoke exposure and photoaging [19]. It has also been shown that newly synthesized elastin fibers may be rendered defective via inhibition of lysyl oxidase-mediated crosslinking of tropoelastin monomers in the presence of tobacco smoke [38]. Moreover, tobacco smoke exposure is known to exert its toxic effects through a multitude of mechanisms including oxidative stress, free radical damage, pro-inflammatory cytokine release, and the activation of cellular inflammatory response pathways [39]. Persistent systemic inflammation, driven by a heterogeneous array of pathological cellular processes, is an important finding in COPD that is associated with poorer clinical outcomes [40, 41]. Remodeling of the ECM by various MMPs is modulated by pro-inflammatory cytokines such as TNFα, IL-1α, and TGFβ, which are implicated in the pathogenesis of emphysema [42,43,44]. Though we did not find elevated plasma levels of TNFα, possibly as a result of its short plasma half-life [45], there was a significant association between lower skin elasticity and the more stable soluble TNFα receptors, TNFR1 and TNFR2, which are better indicators for overall activation of the TNFα system [46]. Increased levels of the acute phase reactants CRP and SAA were also associated with decreased skin elasticity that remained significant after correction for smoking history and degree of airflow obstruction.

Mutations in the promoter variants for MMP-1 and MMP-3 represent genetic susceptibility risk factors for an association between facial wrinkling and airflow obstruction [47]. Indicative of shared systems biology, it is notable that cutis laxa, a rare genetic condition caused by mutations in key structural components of elastic fibers (i.e. elastin, fibulin-4, and fibulin-5), manifests with excess inelastic skin and pulmonary emphysema [22]. We found that elevated plasma levels of MMP-1, and cognate tissue metalloproteinase inhibitors, TIMP-1, TIMP3, and TIMP4, were significantly associated with decreased skin VE. Dysregulation of tissue proteinase activity in our cohort is possibly a result of heightened systemic inflammation as shown in our data, or conceivably due to ECM damage with consequent activation of matrikine signaling pathways [48, 49]. There is biological plausibility for the association of MMP/TIMP balance with skin elasticity in our study as it has an important role in the regulation of elastin and collagen degradation of the ECM in the lung [50] and the skin [51]. Hence, loss of skin elasticity may be an important systemic manifestation of inflammatory and extracellular protease pathway activation with implications for matrix degradation in the lung. It is notable that a recent study employing skin autofluorescence measurements revealed an independent association between the accumulation of advanced glycosylation end products (AGEs) in the skin and parameters of lung function in subjects with COPD [52]. In keeping with our findings, the authors reported that AGEs were increased only in smokers susceptible to developing COPD and correlated strongly with the severity of airflow obstruction. Collectively, there is mounting evidence that affirms the biological plausibility underlying the association of pulmonary disease phenotypes with alterations in skin biology in tobacco-exposed individuals.

Given the racial demographics of the University of Pittsburgh SCCOR cohort our study was restricted to Caucasians only, which limits the applicability of our findings to people of a different race but avoids a potential confounding impact on the analysis [53]. Our study cohort differs from Patel et al., who described an association between facial wrinkling and airflow obstruction [13], with respect to an older age of our study population (median 70.4 vs 56.0 years) and thus a higher prevalence and severity of facial wrinkling which may have contributed to reduced variance and a lower power to detect an association with measures of pulmonary function. As we did not directly evaluate skin elastin using invasive or non-invasive techniques, our findings may not relate solely to smoke-related elastolysis but reflect other processes such as accelerated aging due to senescent pathway activation [54].

Finally, accelerated facial aging, altered skin texture, and skin wrinkling may influence a smoker’s decision to quit and are important deterrent factors for the uptake of tobacco products [55]. Our characterization of the linked pathology between degradation of the ECM in the skin and lung and advanced skin aging in those with emphysema, as a consequence of tobacco smoke exposure, may be of importance in public health strategies to enhance tobacco control and aid smoking cessation efforts in the general population.

Conclusion

This is the first study to associate the biomechanical properties of skin with the severity of airflow obstruction and pulmonary emphysema. Skin elasticity is strongly and independently associated with airflow obstruction, diffusion impairment, gas trapping, and pulmonary emphysema. Moreover, skin aging appears substantially increased in emphysema-susceptible individuals and loss of skin elasticity is associated with elevated blood biomarkers of inflammation and metalloproteinase activity. The findings of our study support the paradigm of complex systemic biological factors in the pathogenesis of COPD and emphysema in those susceptible to the effects of tobacco smoke. Further research into the mechanistic commonality that underlies destruction and remodeling of the ECM, with resultant loss of pulmonary and cutaneous elasticity, may help elucidate common pathological processes and lead to future developments in the field of emphysema and COPD research.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

AGEs:

advanced glycosylation end products

BMI:

body mass index

COPD:

chronic obstructive pulmonary disease

CRP:

C reactive protein

CT:

computerized tomography

DLCO:

diffusion capacity for carbon monoxide

E:

Young’s elastic modulus

ECM:

extracellular matrix

FEV1:

forced expiratory volume in 1 s

FVC:

forced vital capacity in 1 s

FWS:

facial wrinkling score

GOLD:

Global initiative for obstructive lung disease

HU:

Hounsfield unit

IL-1α:

interleukin-1 alpha

IQR:

interquartile range

LAA%:

low attenuation areas, lung voxels with Hounsfield Unit (HU) values less than − 950

MMP:

matrix metalloproteinase

Perc15:

HU value at the 15th percentile of the HU value histogram of lung voxels

PTX3:

pentraxin 3

r:

radius

RT:

retraction time

RV:

residual volume

SAA:

serum amyloid A

SCCOR:

specialized center of clinically orientated research

SD:

standard deviation

TGFβ:

transforming growth factor beta

TIMP:

tissue inhibitor of metalloproteinase

TLC:

total lung capacity

TNFR:

tumor necrosis factor receptor

TNFα:

tumor necrosis factor alpha

VE:

skin elasticity

VE:

skin viscoelastic modulus

Δ:

delta/difference

References

  1. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010 Sep 1;182(5):693–718.

    Article  PubMed  Google Scholar 

  2. Bon J, Fuhrman CR, Weissfeld JL, Duncan SR, Branch RA, Chang C-CH, et al. Radiographic emphysema predicts low bone mineral density in a tobacco-exposed cohort. Am J Respir Crit Care Med. 2011 Apr 1;183(7):885–90.

    Article  PubMed  Google Scholar 

  3. McAllister DA, Maclay JD, Mills NL, Mair G, Miller J, Anderson D, et al. Arterial stiffness is independently associated with emphysema severity in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;176(12):1208–14.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Watz H, Waschki B, Kirsten A, Müller K-C, Kretschmar G, Meyer T, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009;136(4):1039–46.

    Article  CAS  PubMed  Google Scholar 

  5. Frei A, Muggensturm P, Putcha N, Siebeling L, Zoller M, Boyd CM, et al. Five comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD index. J Clin Epidemiol. 2014;67(8):904–11.

    Article  PubMed  Google Scholar 

  6. Agusti A, Sobradillo P, Celli B. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine. Am J Respir Crit Care Med. 2011;183(9):1129–37.

    Article  PubMed  Google Scholar 

  7. Bon J, Kahloon R, Zhang Y, Xue J, Fuhrman CR, Tan J, et al. Autoreactivity to glucose regulated protein 78 links emphysema and osteoporosis in smokers. PLoS One. 2014;9(9):e105066.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Brusselle GG, Joos GF, Bracke KR. New insights into the immunology of chronic obstructive pulmonary disease. Lancet. 2011;378(9795):1015–26.

    Article  CAS  Google Scholar 

  9. Martinez FJ, Donohue JF, Rennard SI. The future of chronic obstructive pulmonary disease treatment--difficulties of and barriers to drug development. Lancet. 2011;378(9795):1027–37.

    Article  CAS  PubMed  Google Scholar 

  10. Viegi G, Pistelli F, Sherrill DL, Maio S, Baldacci S, Carrozzi L. Definition, epidemiology and natural history of COPD. Eur Respir J. 2007;30(5):993–1013.

    Article  CAS  PubMed  Google Scholar 

  11. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182(5):598–604.

    Article  PubMed  Google Scholar 

  12. Smith BS, Williamson N, McConkey B. Dermal connective tissue in patients with chronic obstructive airways disease. Lancet. 1967 Feb 18;1(7486):341–3.

    Article  CAS  PubMed  Google Scholar 

  13. Patel BD, Loo WJ, Tasker AD, Screaton NJ, Burrows NP, Silverman EK, et al. Smoking related COPD and facial wrinkling: is there a common susceptibility? Thorax. 2006;61(7):568–71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Imokawa G, Ishida K. Biological mechanisms underlying the ultraviolet radiation-induced formation of skin wrinkling and sagging I: reduced skin elasticity, highly associated with enhanced dermal elastase activity, triggers wrinkling and sagging. Int J Mol Sci. 2015;16(4):7753–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Just M, Ribera M, Monsó E, Lorenzo JC, Ferrándiz C. Effect of smoking on skin elastic fibres: morphometric and immunohistochemical analysis. Br J Dermatol. 2007;156(1):85–91.

    Article  CAS  PubMed  Google Scholar 

  16. Kadunce DP, Burr R, Gress R, Kanner R, Lyon JL, Zone JJ. Cigarette smoking: risk factor for premature facial wrinkling. Ann Intern Med. 1991;114(10):840–4.

    Article  CAS  PubMed  Google Scholar 

  17. Ernster VL, Grady D, Miike R, Black D, Selby J, Kerlikowske K. Facial wrinkling in men and women, by smoking status. Am J Public Health. 1995;85(1):78–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Aizen E, Gilhar A. Smoking effect on skin wrinkling in the aged population. Int J Dermatol. 2001;40(7):431–3.

    Article  CAS  PubMed  Google Scholar 

  19. Maclay JD, McAllister DA, Rabinovich R, Haq I, Maxwell S, Hartland S, et al. Systemic elastin degradation in chronic obstructive pulmonary disease. Thorax BMJ Publishing Group Ltd. 2012;67(7):606–12.

    Google Scholar 

  20. Kozel BA, Su C-T, Danback JR, Minster RL, Madan-Khetarpal S, McConnell JS, et al. Biomechanical properties of the skin in cutis laxa. J Investig Dermatol. 2014;134(11):2836–8.

    Article  CAS  PubMed  Google Scholar 

  21. Chandra D, Gupta A, Strollo PJ, Fuhrman CR, Leader JK, Bon J, et al. Airflow limitation and endothelial dysfunction. Unrelated and independent predictors of atherosclerosis. Am J Respir Crit Care Med. 2016 Jul 1;194(1):38–47.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Urban Z, Davis EC. Cutis laxa: intersection of elastic fiber biogenesis, TGFβ signaling, the secretory pathway and metabolism. Matrix Biol. 2014;33:16–22.

    Article  CAS  PubMed  Google Scholar 

  23. Daniell HW. Smoker’s wrinkles. A study in the epidemiology of “crow’s feet”. Ann Intern Med. 1971;75(6):873–80.

    Article  CAS  PubMed  Google Scholar 

  24. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Vol. 26, The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology. 2005. pp. 319–38.

    Article  CAS  PubMed  Google Scholar 

  25. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999;159(1):179–87.

    Article  CAS  PubMed  Google Scholar 

  26. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511–22.

    Article  CAS  PubMed  Google Scholar 

  27. Wilson DO, Weissfeld JL, Balkan A, Schragin JG, Fuhrman CR, Fisher SN, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178(7):738–44.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Kennedy C, Bastiaens MT, Bajdik CD, Willemze R, Westendorp RGJ, Bouwes Bavinck JN, et al. Effect of smoking and sun on the aging skin. J Invest Dermatol. 2003;120(4):548–54.

    Article  CAS  PubMed  Google Scholar 

  29. Pedersen L, Hansen B, Jemec GBE. Mechanical properties of the skin: a comparison between two suction cup methods. Skin Res Technol. 2003;9(2):111–5.

    Article  CAS  PubMed  Google Scholar 

  30. Grove G, Damia J, Grove M, Zerweck C. Suction Chamber Method for Measurement of Skin Mechanics. In: Handbook of Non-Invasive Methods and the Skin, Second Edition. CRC Press; 2013. pp. 593–9. (The DermaLab).

  31. Anthonissen M, Daly D, Fieuws S, Massagé P, Van Brussel M, Vranckx J, et al. Measurement of elasticity and transepidermal water loss rate of burn scars with the Dermalab®. Burns. 2013;39(3):420–8.

    Article  PubMed  Google Scholar 

  32. Gankande TU, Duke JM, Danielsen PL, DeJong HM, Wood FM, Wallace HJ. Reliability of scar assessments performed with an integrated skin testing device - the DermaLab combo(®). Burns. 2014;40(8):1521–9.

    Article  CAS  PubMed  Google Scholar 

  33. Francès C, Boisnic S, Hartmann DJ, Dautzenberg B, Branchet MC, Charpentier YL, et al. Changes in the elastic tissue of the non-sun-exposed skin of cigarette smokers. Br J Dermatol. 1991;125(1):43–7.

    Article  PubMed  Google Scholar 

  34. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(5):770–7.

    Article  CAS  PubMed  Google Scholar 

  35. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, et al. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest. 2006;116(3):753–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Rabinovich RA, Miller BE, Wrobel K, Ranjit K, Williams MC, Drost E, et al. Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD. Eur Respir J. 2016;47(5):1365–73.

    Article  CAS  PubMed  Google Scholar 

  37. Boyd AS, Stasko T, King LE, Cameron GS, Pearse AD, Gaskell SA. Cigarette smoking-associated elastotic changes in the skin. J Am Acad Dermatol. 1999;41(1):23–6.

    Article  CAS  PubMed  Google Scholar 

  38. Laurent P, Janoff A, Kagan HM. Cigarette smoke blocks cross-linking of elastin in vitro. Am Rev Respir Dis. 1983;127(2):189–92.

    CAS  PubMed  Google Scholar 

  39. Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 2010;34(3):J258–65.

    Article  CAS  PubMed  Google Scholar 

  40. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J. 2008;31(6):1334–56.

    Article  CAS  PubMed  Google Scholar 

  41. Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012;7(5):e37483.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Bond M, Fabunmi RP, Baker AH, Newby AC. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 1998;435(1):29–34.

    Article  CAS  PubMed  Google Scholar 

  43. Han YP, Tuan TL, Hughes M, Wu H, Garner WL. Transforming growth factor-beta - and tumor necrosis factor-alpha -mediated induction and proteolytic activation of MMP-9 in human skin. J Biol Chem American Society for Biochemistry and Molecular Biology. 2001;276(25):22341–50.

    CAS  Google Scholar 

  44. Russell REK, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2002;26(5):602–9.

    Article  CAS  PubMed  Google Scholar 

  45. Simó R, Barbosa-Desongles A, Lecube A, Hernandez C, Selva DM. Potential role of tumor necrosis factor-α in downregulating sex hormone-binding globulin. Diabetes. 2012;61(2):372–82.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med. 1992;175(2):323–9.

    Article  CAS  PubMed  Google Scholar 

  47. Vierkötter A, Schikowski T, Sugiri D, Matsui MS, Krämer U, Krutmann J. MMP-1 and -3 promoter variants are indicative of a common susceptibility for skin and lung aging: results from a cohort of elderly women (SALIA). J Investig Dermatol. 2015;135(5):1268–74.

    Article  PubMed  Google Scholar 

  48. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, et al. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med. 2006;12(3):317–23.

    Article  CAS  PubMed  Google Scholar 

  49. Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27.

    Article  CAS  PubMed  Google Scholar 

  50. Ohnishi K, Takagi M, Kurokawa Y, Satomi S, Konttinen YT. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Investig. 1998;78(9):1077–87.

    CAS  PubMed  Google Scholar 

  51. Han YP, Tuan TL, Wu H, Hughes M, Garner WL. TNF-alpha stimulates activation of pro-MMP2 in human skin through NF-(kappa)B mediated induction of MT1-MMP. J Cell Sci. 2001;114(Pt 1):131–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. Hoonhorst SJM, Tam Loi Lo AT, Hartman JE, Telenga ED, van den Berge M, Koenderman L, et al. Advanced glycation end products in the skin are enhanced in COPD. Metab Clin Exp. 2014;63(9):1149–56.

    Article  CAS  PubMed  Google Scholar 

  53. Wesley NO, Maibach HI. Racial (ethnic) differences in skin properties: the objective data. Am J Clin Dermatol. 2003;4(12):843–60.

    Article  PubMed  Google Scholar 

  54. Bruse S, Moreau M, Bromberg Y, Jang J-H, Wang N, Ha H, et al. Whole exome sequencing identifies novel candidate genes that modify chronic obstructive pulmonary disease susceptibility. Hum Genomics. 2016;10(1):1.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Demierre MF, Brooks D, Koh HK, Geller AC. Public knowledge, awareness, and perceptions of the association between skin aging and smoking. J Am Acad Dermatol. 1999;41(1):27–30.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

NIH NHBLI UL1TR001857 (FCS), P50HL084948 (FCS), R21HL129917 (FCS), K23HL126912(DC), R01HL128289 (JB), R01HL090648(ZU), K24HL123342 (AM), and Pennsylvania CURE SAP 4100062224 (FCS).

Author information

Authors and Affiliations

  1. Division of Pulmonary Allergy and Critical Care Medicine Department of Medicine, University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, Kaufmann Building, Suite 1211, 3471 Fifth Ave, Pittsburgh, PA, 15213, USA

    Michael E. O’Brien, Divay Chandra, Robert C. Wilson, Chad M. Karoleski, Yingze Zhang, Alison Morris, Seyed Nouraie, Jessica Bon & Frank C. Sciurba

  2. Department of Radiology, University of Pittsburgh, Pittsburgh, PA, USA

    Carl R. Fuhrman, Joseph K. Leader & Jiantao Pu

  3. Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA

    Alison Morris

  4. Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, USA

    Jessica Bon

  5. Department of Human Genetics Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA

    Zsolt Urban

Authors
  1. Michael E. O’Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Divay Chandra
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert C. Wilson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Chad M. Karoleski
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carl R. Fuhrman
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Joseph K. Leader
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jiantao Pu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yingze Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Alison Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Seyed Nouraie
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jessica Bon
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Zsolt Urban
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Frank C. Sciurba
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MOB, ZU, and FCS conceived and designed the study. MOB, RCW, CMK, CRF, JKL, and YZ acquired the data. MOB. RCW, CRF, JKL, JP, SN, and FCS interpreted and analyzed the data; MOB, DC, AM, JB, and FCS were involved in all aspects of the design, conduct, and data analysis of the study. MOB drafted the manuscript. All authors approved the final manuscript. MOB and FCS are accountable for all aspects of the study.

Corresponding author

Correspondence to Frank C. Sciurba.

Ethics declarations

Ethics approval and consent to participate

Ethical approval was granted by the University of Pittsburgh Institutional Review Board, #MOD0612016–25 / IRB0612016. All subjects provided informed consent to take part in this study.

Consent for publication

Explicit consent for publication was obtained from study subjects for the use of representative images in this manuscript.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Additional file

Additional file 1:

Figure S1. Measurement of Skin Elasticity. A) Skin Elastance was measured on the volar forearm using the Dermalab® skin elasticity unit. Increasing increments of negative pressure were applied to a section, 10 mm in diameter, measuring skin distension in the elevation phase and, upon release of the vacuum, rate of return during the retraction phase. (PPTX 618 kb)

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

O’Brien, M.E., Chandra, D., Wilson, R.C. et al. Loss of skin elasticity is associated with pulmonary emphysema, biomarkers of inflammation, and matrix metalloproteinase activity in smokers. Respir Res 20, 128 (2019). https://doi.org/10.1186/s12931-019-1098-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12931-019-1098-7

Keywords

  • COPD
  • Emphysema
  • Skin
  • Elasticity
  • Metalloprotease
  • Inflammation

Respiratory Research

ISSN: 1465-993X

Contact us